Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Articles

Original Article

USP22-mediated phagocytic evasion promotes immune escape in TP53-inactivated hepatocellular carcinoma

Qifan Zhan1,2,3, Qiaonan Shan4, Jianan Xiang5, Shengju Xu6, Jiapei Wang4, Jiongjie Yu7, Guangjiang Jiang4, Mingwei Gao8, Shuqi Cai3, Qianwei Ye6, Chenyang Zhou2, Nasha Qiu6, Lu Yin9, Mingcheng Wan6, Tingting Feng10, Haiyang Xie4, Zi Yin11, Rui Shao12, Yishan Chen13, Leiming Chen4, Nan Wang14, Jimin Liu15, Wei Zhang16, Yiren Hu2, Zhe Tang1, Shusen Zheng4, Lixing Zhan17, Xiao Xu18, Sunbin Ling2,3
Published online: October 27, 2026
1Department of Surgery, Center for Cancer Medicine, the Fourth Affiliated Hospital of School of Medicine, International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China
2Department of General Surgery, Affiliated Wenzhou People's Hospital, Hangzhou Medical College, Wenzhou, 325005, China
3General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), School of Clinical Medicine, Hangzhou Medical College, Hangzhou 310014, China
4Department of Hepatobiliary and Pancreatic Surgery, NHC Key Laboratory of Combined Multi-organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China
5Institute of Translational Medicine, Zhejiang University, Hangzhou,310016, China
6Department of General Surgery, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310003, China
7Department of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China
8Division of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China
9Department of Immunology, Harbin Medical University, Harbin 150081, China
10Department of Colorectal Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, 310022, China
11Department of Orthopedic Surgery of Sir Run Run Shaw Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, 310016, China
12Institute of Microsurgery on Extremities,and Department of Orthopedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China
13Zhejiang University-University of Edinburgh Institute, Zhejiang University International Campus, Haining, 314400, China
14Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Hangzhou,311121, China
15Department of Pathology and Laboratory Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada
16Geriatric Medicine Center, Department of Endocrinology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, China
17Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China
18Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China
Corresponding author:  Lixing Zhan,
Email: lxzhan@sinh.ac.cn
Xiao Xu,
Email: zjxu@zju.edu.cn
Sunbin Ling,
Email: lsb0330@zju.edu.cn

Qifan Zhan, Qiaonan Shan, Jianan Xiang, Shengju Xu and Jiapei Wang contributed equally to this study as co-first authors.
Received: 17 July 2026   • Revised: 10 October 2026   • Accepted: 13 October 2026
  • 660 Views
  • 85 Download
  • 0 Crossref
  • 0 Scopus

Background/Aims
Hepatocellular carcinoma (HCC) is characterized by an immunosuppressive tumor microenvironment. Here, we aimed to elucidate the tumor cell-intrinsic functions of ubiquitin-specific protease 22 (USP22) in the immune escape of HCC cells.
Methods
Autochthonous mouse models of HCC with either genetic Usp22 loss or Trp53 knockdown were used. In vitro and in vivo phagocytosis assays were performed to evaluate the interactions between HCC cells and macrophages. Multicolor fluorescence, spatial transcriptomics, immunoprecipitation and ubiquitination assays were used to explore the potential underlying mechanisms.
Results and Conclusions
We observed that tumor cell-intrinsic USP22 inhibits the infiltration and anticancer function of tumoricidal macrophages in HCC. USP22 expression in HCC cells blocks their direct phagocytosis by tumoricidal macrophages. Mechanistically, CD24 (a known phagocytosis checkpoint) mediates USP22-induced suppression of phagocytosis. USP22 promotes the transcriptional expression of CD24 by deubiquitinating and stabilizing the transcription factor E2F7. Furthermore, wild-type p53 downregulates USP22 protein expression, whereas TP53 inactivation markedly upregulates USP22 protein expression. The USP22-E2F7-CD24 axis is responsible for mediating TP53-inactivation-induced phagocytic evasion and hepatocarcinogenesis. Mechanistically, USP22 proteins bind to one another and suppress ubiquitination at the K442 residue. The wild-type p53 protein disrupts this mutual deubiquitination, thereby facilitating USP22 degradation. Moreover, TNF secreted by tumoricidal macrophages promotes USP22 degradation by disrupting its self-stabilizing mechanism in a wild-type p53-dependent manner. Our findings indicate that USP22-E2F7-CD24 axis-mediated phagocytic evasion promotes immune escape in TP53-inactivated HCC.

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

USP22-mediated phagocytic evasion promotes immune escape in TP53-inactivated hepatocellular carcinoma
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:
Include:
USP22-mediated phagocytic evasion promotes immune escape in TP53-inactivated hepatocellular carcinoma
Close